In the fragile terrain where immunity meets the brain, a protein called PD-1 has long served as a quiet arbiter — restraining the immune system's zeal to protect the very organ it defends. Researchers at Penn State College of Medicine have now mapped this negotiation in precise cellular terms, revealing that it is the CD4+ T cell, not the CD8+ soldier, that holds the balance between clearing a deadly brain virus and igniting the inflammation that destroys neural tissue. The finding arrives as a clarifying light for clinicians who have watched PD-1 checkpoint inhibitors rescue some patients wit
PD-1 Checkpoint Balances Viral Control Against Brain Inflammation in Polyomavirus Infection
Progressive multifocal leukoencephalopathy is a life-threatening brain disease affecting immunocompromised patients, with variable treatment outcomes affecting patient survival and neurological function.